182 related articles for article (PubMed ID: 2457249)
21. Strategies for heterogeneous enzyme immunoassays for tumor markers.
King WJ; Tomita JT; Dowell BL; Delfert DM
Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
[No Abstract] [Full Text] [Related]
22. [Serum markers in malignant diseases].
Peter HH
Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
[No Abstract] [Full Text] [Related]
23. Tumour markers in urology: aids in cancer diagnosis and management.
Wahren B
Urol Res; 1979 Jun; 7(2):57-67. PubMed ID: 89748
[No Abstract] [Full Text] [Related]
24. Tumor markers in testis cancer.
Klein EA
Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic criteria for the tumor markers of the body fluids].
Konishi K; Nakagawa S; Watanabe K; Takamura S
Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536
[No Abstract] [Full Text] [Related]
26. [Diagnosis of tumors with the use of immunologic tumor markers].
Vorlaender KO
Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
[No Abstract] [Full Text] [Related]
27. [Old and new tumor markers].
Dahlmann N
Dtsch Med Wochenschr; 1989 Nov; 114(47):1848-53. PubMed ID: 2479510
[No Abstract] [Full Text] [Related]
28. [Radioimmunoassays in oncology].
Dressler J
Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
[TBL] [Abstract][Full Text] [Related]
29. [Significance of tumor markers in clinical oncology].
Gericke D; Drahovsky D
Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
[No Abstract] [Full Text] [Related]
30. The potential value of immunoperoxidase techniques in diagnostic cytology.
Nadji M
Acta Cytol; 1980; 24(5):442-7. PubMed ID: 6159759
[TBL] [Abstract][Full Text] [Related]
31. [Tumor markers].
Cohen AD; Cohen Y
Harefuah; 1993 Oct; 125(7-8):243-6. PubMed ID: 7693557
[No Abstract] [Full Text] [Related]
32. [Tumor markers in malignancies of the gastrointestinal tract].
von Kleist S; Hohneck A
Internist (Berl); 1982 Jan; 23(1):10-2. PubMed ID: 6175599
[No Abstract] [Full Text] [Related]
33. [Alpha-fetoprotein and chorionic gonadotropin in seminoma of the testis].
Sakalo VS; Romanenko AM; Persidskiĭ IuV; Iugrinova LG
Urol Nefrol (Mosk); 1988; (2):46-50. PubMed ID: 2455374
[No Abstract] [Full Text] [Related]
34. Serum and cellular biologic tumor markers in patients with urologic cancer.
Javadpour N
Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
Wagener C; Breuer H
J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
[No Abstract] [Full Text] [Related]
36. Advances in biological markers for cancer.
Klavins JV
Ann Clin Lab Sci; 1983; 13(4):275-80. PubMed ID: 6194735
[TBL] [Abstract][Full Text] [Related]
37. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
Sorio C; Mauri P; Pederzoli P; Scarpa A
IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
[TBL] [Abstract][Full Text] [Related]
38. Tumor markers in testis tumors.
Kansu E
Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661
[No Abstract] [Full Text] [Related]
39. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
40. [Tumor markers. Current knowledge and practical usefulness].
Papaleo G; Sacerdoti G; Zito GA
Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
